Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.

@article{Seo2009OutcomesOC,
  title={Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.},
  author={Yuji Seo and Michael T. Kinsella and Harry L. Reynolds and Gregory Chipman and Scot C. Remick and Timothy J. Kinsella},
  journal={International journal of radiation oncology, biology, physics},
  year={2009},
  volume={75 1},
  pages={143-9}
}
PURPOSE Information is limited as to how we should treat invasive anal squamous cell carcinoma (SCC) in patients with chronic immunosuppression, since the majority of clinical studies to date have excluded such patients. The objective of this study is to compare treatment outcomes in immunocompetent (IC) versus immunodeficient (ID) patients with invasive anal SCC treated similarly with combined modality therapy. METHODS AND MATERIALS Between January 1999 and March 2007, a total of 36… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 31 extracted citations

Azidothymidine enhances fluorodeoxyuridine-mediated radiosensitization.

International journal of radiation oncology, biology, physics • 2010
View 4 Excerpts
Highly Influenced

Deutsch-Österreichische S2k-Leitlinie: anale Dysplasien und Analkarzinome bei HIV-Infizierten: Prävention, Diagnostik und Therapie.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG • 2015

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Cancer statistics, 2008.

CA: a cancer journal for clinicians • 2008

Including persons with HIV infection in cancer clinical trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2008

Similar Papers

Loading similar papers…